These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 19556337)
1. Allergic reactions to oxaliplatin in a single institute in Japan. Ichikawa Y; Goto A; Hirokawa S; Kijima M; Ishikawa T; Chishima T; Suwa H; Yamamoto H; Yamagishi S; Osada S; Ota M; Fujii S Jpn J Clin Oncol; 2009 Sep; 39(9):616-20. PubMed ID: 19556337 [TBL] [Abstract][Full Text] [Related]
3. [The prognosis of patients with an allergic reaction in the treatment of mFOLFOX6 therapy]. Okada N; Ishibashi K; Kuwabara K; Ishiguro T; Hatano S; Hokama N; Tajima Y; Ishii M; Kubota S; Chika N; Miyazaki T; Ishida H Gan To Kagaku Ryoho; 2009 Nov; 36(12):1985-7. PubMed ID: 20037299 [TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions to oxaliplatin in two asian patients. Ng CV Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290 [TBL] [Abstract][Full Text] [Related]
5. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer. Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180 [TBL] [Abstract][Full Text] [Related]
6. Management of allergic reactions to oxaliplatin in colorectal cancer patients. Suenaga M; Mizunuma N; Shinozaki E; Matsusaka S; Chin K; Muto T; Konishi F; Hatake K J Support Oncol; 2008; 6(8):373-8. PubMed ID: 19149322 [TBL] [Abstract][Full Text] [Related]
7. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer. Nozawa H; Muto Y; Yamada Y Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan. Shibata Y; Ariyama H; Baba E; Takii Y; Esaki T; Mitsugi K; Tsuchiya T; Kusaba H; Akashi K; Nakano S Int J Clin Oncol; 2009 Oct; 14(5):397-401. PubMed ID: 19856046 [TBL] [Abstract][Full Text] [Related]
9. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX). Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215 [No Abstract] [Full Text] [Related]
10. [Drug information brochure for patients undergoing FOLFOX 4 chemotherapy based on survey of adverse reactions]. Imada H; Kawakami K; Hiraoka T; Higuchi S; Takahashi G; Aoyama T; Shinozaki E; Suenaga M; Matsuzaka S; Hama T Gan To Kagaku Ryoho; 2007 Sep; 34(9):1425-30. PubMed ID: 17876140 [TBL] [Abstract][Full Text] [Related]
12. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. Milla P; Airoldi M; Weber G; Drescher A; Jaehde U; Cattel L Anticancer Drugs; 2009 Jun; 20(5):396-402. PubMed ID: 19287306 [TBL] [Abstract][Full Text] [Related]
13. Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate. Wrzesinski SH; McGurk ML; Donovan CT; Ferencz TM; Saif MW Anticancer Drugs; 2007 Jul; 18(6):721-4. PubMed ID: 17762403 [TBL] [Abstract][Full Text] [Related]
14. Leucovorin-induced hypersensitivity reaction. Damaske A; Ma N; Williams R J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170 [TBL] [Abstract][Full Text] [Related]
15. Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Argyriou AA; Polychronopoulos P; Iconomou G; Koutras A; Makatsoris T; Gerolymos MK; Gourzis P; Assimakopoulos K; Kalofonos HP; Chroni E Acta Oncol; 2007; 46(8):1131-7. PubMed ID: 17851880 [TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review. Kim BH; Bradley T; Tai J; Budman DR Oncology; 2009; 76(4):231-8. PubMed ID: 19246947 [TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Thomas RR; Quinn MG; Schuler B; Grem JL Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487 [TBL] [Abstract][Full Text] [Related]